|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
-5.15/-3.86
|
企業價值
2.88B
|
資產負債 |
每股賬面淨值
7.66
|
現金流量 |
現金流量率
--
|
損益表 |
收益
5.45M
|
每股收益
--
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘:2024/06/14 03:32 EDT
同行比較之報價最少15分鐘延遲
業務概覽
|
|||
SpringWorks Therapeutics Inc is a clinical stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several otherprograms addressing highly prevalent, genetically defined cancers. |